Brief: Consun Pharmaceutical Group Posts 525% Jump In FY Profit Attributable
March 23 (Reuters) - Consun Pharmaceutical Group Ltd
1681.HK :
* FY PROFIT ATTRIBUTABLE RMB498.8 MILLION, UP 524.9%
* PROPOSED TO DECLARE A FINAL DIVIDEND OF HKD0.20 PER SHARE
* FY REVENUE RMB1.75 BILLION, UP 1.4%
Source text for Eikon: ID:nHKS26VlVX
Further company coverage: 1681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Consun Pharmaceutical
See all newsChina's Consun Pharmaceutical H1 revenue rises on sales network expansion
Brief: Consun Pharmaceutical Says Unit To Invest RMB191.4 Mln In Shanghai Huamao Pharmaceutical
Brief: Consun Pharmaceutical Group Announces Share Repurchase Program Up To HKD200 Million
Brief: Consun Pharmaceutical Logs FY Revenue RMB 3,420 Mln
Brief: Consun Pharmaceutical Says Executive Director Zhu Quan Redesignated As Non-Executive Director